期刊文献+

Immune responses in mice to oral administration of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit by a lavage technique

Immune responses in mice to oral administration of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit by a lavage technique
在线阅读 下载PDF
导出
摘要 Objective: To determine whether attenuated Salmonella typhimurium producing Helicobacter pylori (Hp) urease subunit B(UreB)can elicit specific immune responses against Hp in mice tested by a lavage technique. Methods: Attenuated Salmonella typhimurium producing Hp UreB immunized orally Balb/c mice twice at a 3-week interval. After 12 weeks,mice intestinal secretions were obtained without harm by administering a lavage solution intragastrically. The mice intestinal secretions of immune group were also directly washed out after the mice were killed. The antibody responses were evaluated by using serum and intestinal fluid with ELISA assay. Results: The multiple oral immunizations with SL3261/ pTC01-UreB induced significantly Hp-specific mucosal IgA response as well as serum IgG response. The IgA was also consistently higher in the intestinal fluid obtained by the lavage solution than by direct washout. In addition, no obvious side effects and changes in gastric inflammation were observed in mice. Conclusion: The attenuated Salmonella typhimurium expressing Hp UreB may be used as an oral vaccine against Hp infection. And the lavage technique is an ideal method in the study of mucosal immune responses. Objective: To determine whether attenuated Salmonella typhimurium producing Helicobacter pylori (Hp) urease subunit B(UreB)can elicit specific immune responses against Hp in mice tested by a lavage technique. Methods: Attenuated Salmonella typhimurium producing Hp UreB immunized orally Balb/c mice twice at a 3-week interval. After 12 weeks, mice intestinal secretions were obtained without harm by administering a lavage solution intragastrically. The mice intestinal secretions of immune group were also directly washed out after the mice were killed. The antibody responses were evaluated by using serum and intestinal fluid with ELISA assay. Results: The multiple oral immunizations with SL3261/pTC01-UreB induced significantly Hp-specific mucosal IgA response as well as serum IgG response. The IgA was also consistently higher in the intestinal fluid obtained by the lavage solution than by direct washout. In addition, no obvious side effects and changes in gastric inflammation were observed in mice. Conclusion: The attenuated Salmonella typhimurium expressing Hp UreB may be used as an oral vaccine against Hp infection. And the lavage technique is an ideal method in the study of mucosal immune responses.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2006年第6期365-368,共4页 中国人民解放军军医大学学报(英文版)
关键词 Helicobacter pylori lavage technique Salmonella typhimurium VACCINE 免疫系统 疫苗 灌洗方法 沙门氏菌 幽门
作者简介 Corresponding author: LIU Xiao-feng. E-mail:liuxf0531@126.com
  • 相关文献

参考文献12

  • 1[1]Rupnow MF,Shachter RD,Owens DK et al.Quantifying the population impact of a prophylactic Helicobacter pylori vaccine[J].Vaccine,2001; 20(5-6):879.
  • 2[2]Liu XF,Hu JL,Zhang X et al.Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit[J].Chin Med J,2002; 115(10):1507.
  • 3[3]Elson CO,Ealding W,Lefkowitz J.A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions[J].J Immunol Meth,1984; 67(1):101.
  • 4[4]Sambrook J,Fritsch EF,Maniatis T.Molecular Cloning:A Laboatory Manual (2nd ed)[M].Cold Spring Harbor Laboato ry Press,1989:889.
  • 5[5]Correa P.Bacterial infections as a cause of cancer[J].J Natl Cancer Inst,2003; 95(7):E3.
  • 6[6]Hatzifoti C,Roussel Y,Harris AG et al.Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori[J].Helicobacter,2006;11(2):113.
  • 7[7]Dougan G,Huett A,Clare S.Vaccines against human enteric bacterial pathogens[J].Br Med Bull,2002; 62(1):113.
  • 8[8]Rupnow MF,Owens DK,Shachter R et al.Helicobacter pylori vaccine development and use:a cost-effectiveness analysis using the Institute of Medicine Methodology[J].Helicobacter,1999;4(4):272.
  • 9[9]Svennerholm AM.Prospects for a mucosally-administered vaccine against Helicobacter pylori[J].Vaccine.2003; 21 (5-6):347.
  • 10[10]Masteroeni P,Howe F,Cahill R et al.Vaccines against gut pathogens[J].Gut,1999; 45 (5):633.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部